Bank of Montreal’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,249
Closed -$1.24K 4170
2022
Q2
$1.24K Buy
+4,249
New +$1.09M ﹤0.01% 2179
2021
Q2
Sell
-306
Closed -$145K 4088
2021
Q1
$145K Sell
306
-255
-45% -$272K ﹤0.01% 3236
2020
Q4
$539K Buy
561
+370
+194% +$389K ﹤0.01% 2657
2020
Q3
$203K Sell
191
-111
-37% -$119K ﹤0.01% 2738
2020
Q2
$316K Sell
302
-468
-61% -$435K ﹤0.01% 2494
2020
Q1
$655K Buy
770
+70
+10% +$69.6K ﹤0.01% 1868
2019
Q4
$751K Sell
700
-1,990
-74% -$2.03M ﹤0.01% 2444
2019
Q3
$2.49M Buy
2,690
+2,413
+871% +$2.65M ﹤0.01% 1538
2019
Q2
$313K Buy
277
+247
+823% +$270K ﹤0.01% 2689
2019
Q1
$40K Sell
30
-39
-57% -$52.9K ﹤0.01% 3423
2018
Q4
$80K Buy
69
+44
+176% +$49.5K ﹤0.01% 3064
2018
Q3
$37K Buy
25
+2
+9% +$3.08K ﹤0.01% 3505
2018
Q2
$36K Buy
23
+21
+1,050% +$27.4K ﹤0.01% 3544
2018
Q1
$2K Sell
2
-125
-98% -$165K ﹤0.01% 4051
2017
Q4
$151K Buy
127
+121
+2,017% +$152K ﹤0.01% 2807
2017
Q3
$8K Buy
+6
New +$6.32K ﹤0.01% 3763
2016
Q2
Sell
-19
Closed -$10K 4154
2016
Q1
$10K Hold
19
﹤0.01% 3624
2015
Q4
$15K Hold
19
﹤0.01% 3489
2015
Q3
$11K Buy
+19
New +$11.5K ﹤0.01% 3440
2015
Q2
Sell
-120
Closed -$94K 3980
2015
Q1
$94K Buy
+120
New +$93K ﹤0.01% 2650

Other funds holding KYNB

Bank of Montreal's KYNB Position: Q3 2022 in Review

Bank of Montreal sold out of Kyntra Bio (KYNB) in Q3 2022, closing a stake of 4,249 shares — an estimated $1.24K sold.

Bank of Montreal first reported a position in KYNB in Q1 2015 and held it in 20 quarters. The position peaked at $2.49M in Q3 2019. 152 funds tracked by Wall St. Rank hold KYNB as of Q3 2022.

  • Bank of Montreal reported no remaining Kyntra Bio position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 4,249 Kyntra Bio shares in Q3 2022, an estimated $1.24K.
  • Bank of Montreal first reported a position in Kyntra Bio in Q1 2015 and held it in 20 quarters.
  • Bank of Montreal's Kyntra Bio position peaked at $2.49M in Q3 2019.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.